[1]
Tansu Yamazhan et al. 2020. Real-life experience of ledipasvir and sofosbuvir single-tablet regimen among chronic hepatitis C patients in Turkey . Turkish Journal of Gastroenterology. 31, 3 (Apr. 2020), 239–245.